BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14665714)

  • 1. Alzheimer's disease: pathophysiological implications of measurement of plasma cortisol, plasma dehydroepiandrosterone sulfate, and lymphocytic corticosteroid receptors.
    Armanini D; Vecchio F; Basso A; Milone FF; Simoncini M; Fiore C; Mattarello MJ; Sartorato P; Karbowiak I
    Endocrine; 2003 Nov; 22(2):113-8. PubMed ID: 14665714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia.
    Murialdo G; Barreca A; Nobili F; Rollero A; Timossi G; Gianelli MV; Copello F; Rodriguez G; Polleri A
    J Endocrinol Invest; 2001 Mar; 24(3):139-46. PubMed ID: 11314741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD).
    Leblhuber F; Neubauer C; Peichl M; Reisecker F; Steinparz FX; Windhager E; Dienstl E
    Psychopharmacology (Berl); 1993; 111(1):23-6. PubMed ID: 7870929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
    Guazzo EP; Kirkpatrick PJ; Goodyer IM; Shiers HM; Herbert J
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients.
    Aldred S; Mecocci P
    Arch Gerontol Geriatr; 2010; 51(1):e16-8. PubMed ID: 19665809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia.
    Näsman B; Olsson T; Bäckström T; Eriksson S; Grankvist K; Viitanen M; Bucht G
    Biol Psychiatry; 1991 Oct; 30(7):684-90. PubMed ID: 1835658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal perfusion and pituitary-adrenal axis in Alzheimer's disease.
    Murialdo G; Nobili F; Rollero A; Gianelli MV; Copello F; Rodriguez G; Polleri A
    Neuropsychobiology; 2000; 42(2):51-7. PubMed ID: 10940758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls.
    Carlson LE; Sherwin BB; Chertkow HM
    Horm Behav; 1999 Jun; 35(3):254-63. PubMed ID: 10373337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone effects on cortisol secretion in Alzheimer's disease: some clinical and hormonal features in suppressor and nonsuppressor patients.
    Murialdo G; Barreca A; Nobili F; Rollero A; Timossi G; Gianelli MV; Copello F; Rodriguez G; Polleri A
    J Endocrinol Invest; 2000 Mar; 23(3):178-86. PubMed ID: 10803476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the stress response: role of anxiety, cortisol and DHEAs].
    Boudarene M; Legros JJ; Timsit-Berthier M
    Encephale; 2002; 28(2):139-46. PubMed ID: 11972140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia.
    Bernardi F; Lanzone A; Cento RM; Spada RS; Pezzani I; Genazzani AD; Luisi S; Luisi M; Petraglia F; Genazzani AR
    Eur J Endocrinol; 2000 May; 142(5):466-71. PubMed ID: 10802523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal serum dehydroepiandrosterone sulphate concentration does not predict the cortisol response to provocative testing.
    Littley MD; Pollock A; Kane J; Shalet SM
    Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():557-61. PubMed ID: 2150469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease.
    Masera RG; Prolo P; Sartori ML; Staurenghi A; Griot G; Ravizza L; Dovio A; Chiappelli F; Angeli A
    Psychoneuroendocrinology; 2002 May; 27(4):447-61. PubMed ID: 11911998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortisol and dehydroepiandosterone sulfate plasma levels and their relationship to aging, cognitive function, and dementia.
    de Bruin VM; Vieira MC; Rocha MN; Viana GS
    Brain Cogn; 2002 Nov; 50(2):316-23. PubMed ID: 12464198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol/DHEA ratio and hippocampal volume: A pilot study in major depression and healthy controls.
    Jin RO; Mason S; Mellon SH; Epel ES; Reus VI; Mahan L; Rosser RL; Hough CM; Burke HM; Mueller SG; Wolkowitz OM
    Psychoneuroendocrinology; 2016 Oct; 72():139-46. PubMed ID: 27428086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease.
    Näsman B; Olsson T; Fagerlund M; Eriksson S; Viitanen M; Carlström K
    Biol Psychiatry; 1996 Mar; 39(5):311-8. PubMed ID: 8704061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving antiepileptic drug treatment.
    Galimberti CA; Magri F; Copello F; Arbasino C; Cravello L; Casu M; Patrone V; Murialdo G
    Epilepsia; 2005 Apr; 46(4):517-23. PubMed ID: 15816945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and noncognitive symptoms in dementia patients: relationship to cortisol and dehydroepiandrosterone.
    Miller TP; Taylor J; Rogerson S; Mauricio M; Kennedy Q; Schatzberg A; Tinklenberg J; Yesavage J
    Int Psychogeriatr; 1998 Mar; 10(1):85-96. PubMed ID: 9629527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease.
    Rasmuson S; Näsman B; Olsson T
    Int Psychogeriatr; 2011 Nov; 23(9):1386-92. PubMed ID: 21729423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of corticosteroid receptors in patients with anorexia nervosa and Cushing's syndrome.
    Armanini D; Spinella P; Simoncini M; Basso A; Zovato S; Pozzan GB; De Palo CB; Bucciante G; Karbowiak I
    J Endocrinol; 1998 Sep; 158(3):435-9. PubMed ID: 9846173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.